Products
Platform
Research
Market
Learn
Torrent Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 3,275.00 | 3,141.00 | 2,941.00 | 2,842.00 | 2,873.00 |
| Other Income Qtr Cr | -27.00 | -37.00 | -18.00 | 33.00 | -16.00 |
| Operating Revenues Qtr | 3,302.00 | 3,178.00 | 2,959.00 | 2,809.00 | 2,889.00 |
Loading chart... | |||||
Operating Expenses Qtr | 2,219.00 | 2,146.00 | 1,995.00 | 1,895.00 | 1,950.00 |
Operating Profit Qtr | 1,083.00 | 1,032.00 | 964.00 | 914.00 | 939.00 |
EBITDA Qtr Cr | 1,043.00 | 995.00 | 922.00 | 947.00 | 923.00 |
Depreciation Qtr | 204.00 | 201.00 | 201.00 | 199.00 | 198.00 |
Net Profit Qtr | 591.00 | 548.00 | 498.00 | 503.00 | 453.00 |
Basic EPS Qtr | 17.45 | 16.19 | 14.71 | 14.88 | 13.37 |
Open Demat Account
Open Demat Account